Abstract
Objectives
To adopt the FAIR principles (Findable, Accessible, Interoperable, Reusable) to enhance data sharing, the Cure Sickle Cell Initiative (CureSCi) MetaData Catalog (MDC) was developed to make Sickle Cell Disease (SCD) study datasets more Findable by curating study metadata and making them available through an open-access web portal.
Methods
Study metadata, including study protocol, data collection forms, and data dictionaries, describe information about study patient-level data. We curated key metadata of 16 SCD studies in a three-tiered conceptual framework of category, subcategory, and data element using ontologies and controlled vocabularies to organize the study variables. We developed the CureSCi MDC by indexing study metadata to enable effective browse and search capabilities at three levels: study, Patient-Reported Outcome (PRO) Measures, and data element levels.
Results
The CureSCi MDC offers several browse and search tools to discover studies by study level, PRO Measures, and data elements. The “Browse Studies,” “Browse Studies by PRO Measures,” and “Browse Studies by Data Elements” tools allow users to identify studies through pre-defined conceptual categories. “Search by Keyword” and “Search Data Element by Concept Category” can be used separately or in combination to provide more granularity to refine the search results. This resource helps investigators find information about specific data elements across studies using public browsing/search tools, before going through data request procedures to access controlled datasets. The MDC makes SCD studies more Findable through browsing/searching study information, PRO Measures, and data elements, aiding in the reuse of existing SCD data.
Funder
National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health
Publisher
Public Library of Science (PLoS)
Reference33 articles.
1. Population estimates of sickle cell disease in the U.S;KL Hassell;Am J Prev Med,2010
2. Curesickle.org [Internet]. It’s time to rewrite the story of sickle cell. Available from https://curesickle.org/
3. Standard measures for sickle cell disease research: the PhenX Toolkit sickle cell disease collections;JR Eckman;Blood Adv,2017
4. End points for sickle cell disease clinical trials: patient-reported outcomes;AT Farrell;pain,2019
5. End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings;AT Farrell;Blood Adv,2019